Stay updated on XmAb®18087 in NET and GIST Clinical Trial
Sign up to get notified when there's something new on the XmAb®18087 in NET and GIST Clinical Trial page.

Latest updates to the XmAb®18087 in NET and GIST Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.0 added. Revision: v3.4.3 removed.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and the prior Revision: v3.4.1 notice.SummaryDifference0.4%

- Check46 days agoChange DetectedThe page now displays a government funding lapse notice and a version update (Revision: v3.4.1), replacing the prior version (v3.4.0); These changes do not modify core study content such as the study data, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedThe changes are limited to page metadata and UI elements (Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0) and do not modify core trial details such as eligibility, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check67 days agoChange DetectedRevision note updated from v3.3.3 to v3.3.4; the page footer now displays the revised version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to XmAb®18087 in NET and GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®18087 in NET and GIST Clinical Trial page.